Supplement Scholar
Mineral

Magnesium Orotate

Buy on Amazon ↗

Affiliate link: we may earn a commission at no extra cost to you. Disclosures

Magnesium Orotate. Magnesium + orotic acid — studied specifically in heart failure and athletic populations.

How it works. Orotate is a pyrimidine precursor that may enhance cardiac energetics via increased ATP/UTP pools.

What the research supports. 2 graded claims. Strongest: Improved 1-year survival in severe heart failure (small RCT) (limited).

How much to take. Typical dose: 3,000–6,000 mg orotate (≈190 mg elemental).

Side effects and interactions. 1 medication interaction listed. Serious: Discontinue and seek medical advice if symptoms are severe, persistent, or include difficulty breathing.

Stacking. Pairs well with Omega-3, CoQ10.

Common forms. Available as Chelated form (glycinate, bisglycinate, citrate, malate), Inorganic salt (oxide, sulfate, chloride), Liquid ionic solution, Topical or transdermal preparation.

Key studies. 9 studies cited. The strongest are listed with links to PubMed.

Community. Experiences from people who have tried Magnesium Orotate. Anecdotes are not medical advice.

Magnesium Orotate. Magnesium + orotic acid — studied specifically in heart failure and athletic populations.

Molecular structureC10H6MgN4O8 · 334.48 g/mol

What it is

Magnesium + orotic acid — studied specifically in heart failure and athletic populations.

Food sources

Whole foods (leafy greens, legumes, nuts, seeds, seafood, animal proteins)Fortified foods such as cereals, breads, plant milks, and table saltMineral supplements as chelates, citrates, glycinates, or inorganic salts

Goals

How it works

Orotate is a pyrimidine precursor that may enhance cardiac energetics via increased ATP/UTP pools.

Pathways

  • Pyrimidine biosynthesis
  • Cardiac ATP

Effects

  • +Improved 1-year survival in severe heart failure (small RCT) supports
  • +Improved exercise tolerance in CAD supports

What the research supports

Improved 1-year survival in severe heart failure (small RCT)limited
Improved exercise tolerance in CADlimited

Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.

Typical dose
3,000–6,000 mg orotate (≈190 mg elemental)
TimingConsistent daily timing recommended; split larger doses if GI tolerance is a concern.
With foodWith food
Best formMost evidence is based on the chelated form (glycinate, bisglycinate, citrate, malate) form.
Shop Magnesium Orotate on Amazon ↗

As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.

Side effects & interactions

Common side effects

  • Magnesium Orotate is generally well-tolerated at evidence-based doses
  • Mild GI discomfort (nausea, loose stools, or bloating) possible at higher intakes
  • Headache or transient fatigue reported by a small fraction of users

Serious

  • Discontinue and seek medical advice if symptoms are severe, persistent, or include difficulty breathing

Medication interactions

Prescription medications (general)minor

Always disclose Magnesium Orotate use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.

Check any supplement–medication combination with your pharmacist before starting.

Combines with

Pairs well

  • Omega-3Anti-inflammatory cardiovascular synergy.
  • CoQ10Supports mitochondrial energetics in cardiac tissue.

Common forms

  • Chelated form (glycinate, bisglycinate, citrate, malate)
  • Inorganic salt (oxide, sulfate, chloride)
  • Liquid ionic solution
  • Topical or transdermal preparation

Key studies

9 studies cited in total.

PubMed: Magnesium Orotate — Improved 1-year survival in severe heart failure ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Magnesium Orotate and "Improved 1-year survival in severe heart failure". Filter by RCT, meta-analysis, or year on the results page.

PubMed: Magnesium Orotate — Improved exercise tolerance in CAD ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Magnesium Orotate and "Improved exercise tolerance in CAD". Filter by RCT, meta-analysis, or year on the results page.

PubMed: Magnesium Orotate — randomized controlled trial ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Magnesium Orotate and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

Discussion

Loading discussion…